SARS, MERS, COVID-19: Repurposing Drugs for a Pan-Coronavirus Treatment Medical Countermeasures October 15, 2020 …
U.S. Invests in Pandemic Vaccine Manufacturing Capacity with $31M Contract to Cytiva Industry News October 15, 2020 …
High Dose Favipiravir Countered SARS-CoV-2 in Hamsters, Hydroxychloroquine Ineffective Medical Countermeasures October 10, 2020 …
Pipeline COVID-19 Vaccines Not Affected by ‘G-Strain’ Mutation Medical Countermeasures October 8, 2020 …
The Challenges of Vaccine Cold-Chain Distribution Must Be Met to End the Pandemic Medical Countermeasures October 5, 2020 …
COVID-19 Anti-Vaxxers Use the Same Arguments From 135 Years Ago Historical Reflections October 4, 2020 …
Operation Warp Speed’s Big Vaccine Contracts Could Stay Secret Medical Countermeasures September 29, 2020 …
Remdesivir: Second Mechanism of Action Against SARS-CoV-2 Revealed in New Study Medical Countermeasures September 23, 2020 …
Scientists Test Drugs Against Virus Samples from First U.S. COVID-19 Patient Medical Countermeasures February 15, 2020 …
China Launches Dozens of Clinical Trials to Identify Most Promising Treatments for COVID-19 Medical Countermeasures February 15, 2020 …
CEPI Launches New Call for Proposals to Develop Vaccines Against Novel Coronavirus Contracts + Grants February 4, 2020 …
